Making a World of Difference

Mission / Strategy

URL Pharma is a best-in-class specialty pharmaceutical company achieving sustainable growth by developing and commercializing safe, innovative, and exclusive medications and technologies.

 

URL Pharma has a 62 year operating history, is highly profitable, generates significant positive cash flow, and has a diversified product portfolio including a deep, mid to late stage branded product and technology pipeline.

 

In the near term, Qualaquin® and licensing deals are expected to be the most significant revenue drivers. We expect to commercialize our six mid to late stage NDA products, over the next five years, with the next launch in 2009. Two NDA filings are on track for 2008 submission.

 

Branded development activities are focused on products for unmet medical needs, or the needs of managed care organizations, and are commercialized via URL Pharma's internal capabilities, partnerships, or licensing agreements. URL Pharma has also developed multiple technologies for drug delivery and product enhancement including NanoBurst™,Z-Burst™, and MultiBurst™ technologies. For more information on these technologies, please click here.

 

Most of our initiatives have intellectual property or regulatory protection. In early 2008, URL Pharma’s patent portfolio included multiple approved US patents, 40 patent applications awaiting approval, and 25 patent applications being drafted.